Previous research demonstrated the role of EMILIN/Multimerins in regulating tumor growth progression (Andreuzzi et al., 2018; Rabajdova et al., 2016) including the association of EMILIN3 in LGG survival rates (Zeng et al., 2018). The gene discussed is EMILIN1; the disease is neoplasm.